Italy Pharmaceuticals and Healthcare Report Q3 2013:Life Sciences Market Research Reports

Life Sciences Market Research Reports

Italy Pharmaceuticals and Healthcare Report Q3 2013 Jun 5th 2013, 00:00 BMI View: The sharp drop in public pharmaceutical expenditure in Italy in 2012 to a level below that of 2001 does not bode well for drugmakers and pharmacies in the country. The success of the implemented policies may encourage the enforcement of further cost-containment measures, which, together with the ongoing public hospital debt situation, seriously hampers the country’s attractiveness as a location in which to sell drugs, despite its favourable demographic characteristics. Headline Expenditure Projections ?? Pharmaceuticals: EUR21.67bn (US$27.86bn) in 2012 to EUR20.36bn (US$27.28bn) in 2013; -6.1% in local currency terms. ?? Healthcare: EUR151.14bn (US$194.32bn) in 2012 to EUR153.60bn (US$205.83bn) … Order / Buy a copy of this report @ http://www.rnrmarketresearch.com/contacts/purchase?rname=99924. Complete report details with Table of Contents and more @ http://www.rnrmarketresearch.com/italy-pharmaceuticals-and-healthcare-report-q3-2013-market-report.html.

You are receiving this email because you subscribed to this feed at blogtrottr.com. If you no longer wish to receive these emails, you can unsubscribe from this feed, or manage all your subscriptions